Report error Found 133 Enz. Inhib. hit(s) with all data for entry = 13460
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 5.45nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 5.55nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 6.44nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 6.66nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 6.68nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 6.84nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 6.86nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 6.88nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 6.92nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.12nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.15nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.17nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.21nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.44nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.54nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.65nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.65nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 7.90nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 9(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 16.8nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 67.6nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 72.6nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 73.6nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 78.8nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 80nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 82nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 5(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 82.9nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 86.7nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 87.1nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 93.2nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 97nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 125nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 133nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 5(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 140nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 152nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 5(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 162nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 5(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 168nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 4(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 184nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 193nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 196nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 4(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 196nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 5(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 209nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 214nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 225nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 5(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 248nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 2(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 253nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 262nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 265nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 4(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 268nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 4(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 273nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO-OX1 or CHO-OX2 cells are seeded into black-walled clear-base 384-well plates (Costar) at a density of 20,00...More data for this Ligand-Target Pair
Ligand Info
TargetCyclin-dependent kinase 2(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
US Patent
Affinity DataIC50: 274nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info


















